| |
|
Form Serial Number: |
DA20260331E00383
|
| 1.
Date of relevant event: |
30/03/2026
(dd/mm/yyyy)
|
| 2.
Date when director became aware of the relevant event/ interest in the shares (if later): |
(dd/mm/yyyy)
|
| 3.
Stock code: |
02496 |
| 4.
Name of listed corporation: |
武漢友芝友生物製藥股份有限公司 - B - H股 |
| 5.
Class of shares: |
Others |
| 6.
Number of issued shares in class: |
14,370,087 |
| 7.
Name of director (English) as printed on HKID Card/Passport: |
| (Surname) |
WEN |
| (Other names) |
Zhicheng |
|
|
|
| 10.
Name of director (Chinese): |
温植成 |
| 11.
Chinese Character Code as printed on HKID Card: |
330627842052 |
| |
| 24.
Details of relevant event: |
|
|
Brief description of relevant event
|
Capacity in which shares were/are held
|
Number of shares bought/sold or involved
|
Currency of transaction |
On Exchange
|
Off Exchange
|
|
Before relevant event
|
After relevant event
|
Highest price (per share)
|
Average price (per share)
|
Average consideration (per share)
|
Consideration code
|
| Long position |
| 1213 | The number of shares in which you are interested has reduced because:
any other event (you must briefly describe the relevant event in the Supplementary Information box) |
|
| 2201 | Interest of corporation controlled by you |
|
|
5,059,039 |
|
|
|
|
|
| Short position |
|
|
|
|
|
|
|
|
|
| |
|
| 25.
Total shares in listed corporation immediately before the relevant event: |
| | Total number of shares | Percentage figure (%) |
| Long position | 5,059,039 | 6.14 |
|
| |
| 26.
Total shares in listed corporation immediately after the relevant event: |
| | Total number of shares | Percentage figure (%) |
| Long position | 0 | 0.00 |
|
| |
| 27.
Capacity in which interests disclosed in Box 26 are held: |
| Code describing capacity | Number of shares |
| | |
|
| |
| 28.
Further information in derivative interests in listed corporation : |
| Derivatives code |
Exercise period (dd/mm/yyyy) |
Consideration - if derivatives granted by listed corporation |
Number of shares |
| | | Begins | Ends | Currency | Price for grant | Currency | Exercise price | Currency | Price on assignment | |
| | | | | | | | | | | |
|
| |
| 29.
Further information in relation to interests of children under 18 and/or spouse: |
| Child/Spouse | Name of child/spouse | Number of shares |
| | |
|
| |
| 30.
Further information in relation to interests of corporations controlled by Director: |
| Name of controlled corporation | Address and place of incorporation | Name of controlling person | % control | Direct interest (Y/N) | Number of shares |
| | | | | |
|
| |
| 31.
Further information in relation to interests held by Director jointly with another person: |
| Name of joint shareholder | Address | Number of shares |
| | |
|
| |
| 32.
Further information from a director who is a trustee, or beneficiary of a trust, or a person who has set up a Discretionary Trust: |
| Names of Trust | Address | Status code | Number of shares |
| | | |
|
| |
| 33.
Further information from a party to an agreement under Section 317 (Please see Notes for further information required): |
| Names of other parties | Address | Number of shares |
| | |
| Total number of shares in which a director is interested under sections 317 and 318 | |
|
| |
| 34.
Supplementary information: |
有關方格5而言，「其他」指武漢友芝友生物製藥股份有限公司(「本公司」)的非上市股份，包括內資股及非上市外資股。溫植成先生自2024年10月22日起擔任本公司的董事。(i) 南寧曜友商務諮詢合夥企業（有限合夥）（「南寧曜友」）爲南寧匯友興曜股權投資基金合夥企業（有限合夥）（「匯友興曜」）的普通合夥人，同德乾元（北京）投資管理有限公司（「同德乾元」）爲南寧曜友的普通合夥人，同德乾元由溫植成擁有約72.38%；及(ii) 共青城曜友投資中心（有限合夥）（「共青城曜友」）爲共青城匯友興曜二期股權投資合夥企業（有限合夥）（「共青城匯友」）的普通合夥人，同德乾元爲共青城曜友的普通合夥人。因此，溫植成被視爲於(i)匯友興曜持有的3,447,526股非上市股份，及(ii)共青城匯友持有的1,611,513股非上市股份中擁有權益。有關方格24而言，本公司於全流通轉換完成後，將68,010,299股非上市股份（包括61,140,555股內資股及6,869,744股非上市外資股）轉換為H股，其中，上述(i) 3,447,526股非上市股份，及(ii) 1,611,513股非上市股份將轉換為H股。
|
| 35.
Log/Serial Number of the previous form: |
|
| 36.
Number of concert party document(s) under section 317 attached/uploaded: |
|
|
Date of filing this Form 3A: |
31/03/2026
(dd/mm/yyyy)
|
| |